Early evaluation of cancer response by a new functional biomarker: Apparent diffusion coefficient

American Journal of Roentgenology

Volumn 197, Issue 1, 2011, Pages

  Sun, Ying Shi ^a   Cui, Yong ^a   Tang, Lei ^a   Qi, Li Ping ^a   Wang, Ning ^a   Zhang, Xiao Yan ^a   Cao, Kun ^a   Zhang, Xiao Peng ^a  

^a PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Apparent diffusion coefficient; Carcinoma; MRI; response

Indexed keywords

BIOLOGICAL MARKER; CAPECITABINE; CARBOPLATIN; CETUXIMAB; CISPLATIN; FLUOROPYRIMIDINE; FLUOROURACIL; FOLINATE CALCIUM; FOLINIC ACID; GEMCITABINE; IRINOTECAN; NAVELBINE; OXALIPLATIN; PACLITAXEL; TEGAFUR;

ADULT; AGED; APPARENT DIFFUSION COEFFICIENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ESOPHAGUS CANCER; FEMALE; HUMAN; LIVER METASTASIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RECTUM CANCER; STOMACH CANCER; TREATMENT RESPONSE; TUMOR VOLUME;

ADULT; AGED; DIFFUSION MAGNETIC RESONANCE IMAGING; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 79960533797     PISSN: 0361803X     EISSN: 15463141     Source Type: Journal    
DOI: 10.2214/AJR.10.4912     Document Type: Article

References (24)

1. Galons JP, Altbach MI, Paine-Murrieta GD, Taylor CW, Gillies RJ. Early increases in breast tumor xenograft water mobility in response to paclitaxel therapy detected by non-invasive diffusion magnetic resonance imaging. Neoplasia 1999; 1:113-117
2. Lemaire L, Howe FA, Rodrigues LM, Griffiths JR. Assessment of induced rat mammary tumour response to chemotherapy using the apparent diffusion coefficient of tissue water as determined by diffusion-weighted 1H-NMR spectroscopy in vivo. MAGMA 1999; 8:20-26 (Pubitemid 29238708)
3. 1H-NMR spectroscopy in a murine tumour in vivo. Br J Cancer 1996; 73:61-64
4. Chenevert TL, McKeever PE, Ross BD. Monitoring early response of experimental brain tumors to therapy using diffusion magnetic resonance imaging. Clin Cancer Res 1997; 3:1457-1466 (Pubitemid 27431551)
5. Poptani H, Puumalainen AM, Gröhn OH, et al. Monitoring thymidine kinase and ganciclovir-induced changes in rat malignant glioma in vivo by nuclear magnetic resonance imaging. Cancer Gene Ther 1998; 5:101-109 (Pubitemid 128639996)
6. 1H nuclear magnetic resonance diffusion spectroscopy of BT4C rat glioma during thymidine kinase-mediated gene therapy in vivo: identification of apoptotic response. Cancer Res 1998; 58:3791-3799
7. Stegman LD, Rehemtulla A, Hamstra DA, et al. Diffusion MRI detects early events in the response of a glioma model to the yeast cytosine deaminase gene therapy strategy. Gene Ther 2000; 7:1005-1010 (Pubitemid 30398348)
8. Yuan YH, Xiao EH, Liu JB. Characteristics and pathological mechanism on magnetic resonance diffusion-weighted imaging after chemoembolization in rabbit liver VX-2 tumor model. World J Gastroenterol 2007; 13:5699-5706
9. Geschwind JF, Artemov D, Abraham S, et al. Chemoembolization of liver tumor in a rabbit model: assessment of tumor cell death with diffusion-weighted MR imaging and histologic analysis. J Vasc Interv Radiol 2000; 11:1245-1255
10. Jennings D, Hatton BN, Guo J, et al. Early response of prostate carcinoma xenografts to docetaxel chemotherapy monitored with diffusion MRI. Neoplasia 2002; 4:255-262 (Pubitemid 34525257)
11. Roth Y, Tichler T, Kostenich G, et al. High-b-value diffusion-weighted MR imaging for pretreatment prediction and early monitoring of tumor response to therapy in mice. Radiology 2004; 232:685-692 (Pubitemid 39100249)
12. Jordan BF, Runquist M, Raghunand N, et al. Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1a using PX-478. Neoplasia 2005; 7:475-485 (Pubitemid 40796142)
13. Mardor Y, Roth Y, Lidar Z, et al. Monitoring response to convection-enhanced taxol delivery in brain tumor patients using diffusion-weighted magnetic resonance imaging. Cancer Res 2001; 61:4971-4973 (Pubitemid 32681520)
14. Chenevert TL, Stegman LD, Taylor JM, et al. Diffusion magnetic resonance imaging: an early surrogate marker of therapeutic efficacy in brain tumors. J Natl Cancer Inst 2000; 92:2029-2036 (Pubitemid 32045900)
15. Dudeck O, Zeile M, Pink D. Diffusion-weighted magnetic resonance imaging allows monitoring of anticancer treatment effects in patients with soft-tissue sarcomas. J Magn Reson Imaging 2008; 27:1109-1113 (Pubitemid 351614624)
16. Sharma U, Danishad KK, Seenu V, Jagannathan NR. Longitudinal study of the assessment by MRI and diffusion-weighted imaging of tumor response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. NMR Biomed 2009; 22:104-113
17. Cui Y, Zhang XP, Sun YS, Tang L, Shen L Apparent diffusion coefficient: potential imaging biomarker for prediction and early detection of response to chemotherapy in hepatic metastases. Radiology 2008; 248:894-900
18. Sun YS, Zhang XP, Tang L, et al. Locally advanced rectal carcinoma treated with preoperative chemotherapy and radiation therapy: preliminary analysis of diffusion-weighted mr imaging for early detection of tumor histopathologic downstaging. Radiology 2010; 254:170-178
19. Koh DM, Collins DJ. Diffusion-weighted MRI in the body: applications and challenges in oncology. AJR 2007; 188:1622-1635 (Pubitemid 46866868)
20. Theilmann RJ, Borders R, Trouard T, et al. Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy. Neoplasia 2004; 6:831-837 (Pubitemid 40041502)
21. Dzik-Jurasz A, Domenig C, George M, et al. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet 2002; 360:307-308 (Pubitemid 34874724)
22. Kremser C, Judmaier W, Hein P, Griebel J, Lukas P, de Vries A. Preliminary results on the influence of chemoradiation on apparent diffusion coefficients of primary rectal carcinoma measured by magnetic resonance imaging. Strahlenther Onkol 2003; 179:641-649 (Pubitemid 37101649)
23. Kim H, Morgan DE, Zeng H, et al. Breast tumor xenografts: diffusion-weighted MR imaging to assess early therapy with novel apoptosis-inducing anti-DR5 antibody. Radiology 2008; 248:844-851
24. Chen ET, Mohiuddin M, Brodovsky H, Fishbein G, Marks G. Downstaging of advanced rectal cancer following combined preoperative chemotherapy and high dose radiation. Int J Radiat Oncol Biol Phys 1994; 30:169-175 (Pubitemid 24291127)